Open Access
Subscription Access
Open Access
Subscription Access
Anticancer Activity of Quercetin on Prostate Cancer Cell Line In vitro
Subscribe/Renew Journal
Recent estimates have placed prostate cancer as the most commonly diagnosed malignancy. It is the fourth most common cancer in men worldwide. Androgen dependent prostate cancer can responds to androgen ablative therapy. However, if the cell contains heterogeneous population of both androgen dependent and androgen independent, the androgen ablative therapy can only responds to androgen dependent cell population but not to independent cancer.
Subscription
Login to verify subscription
User
Font Size
Information
Abstract Views: 291
PDF Views: 0